Reportstack has announced a new market research publication on Ocular Disorders: Rising Therapeutics, Technologies, and Devices. New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while alsoproviding alternative therapeutic options for various ocular complications. In an interview with several companies including Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals, representatives mentioned several technologies and devices in development to improve the current line of therapeutics.
Both invasive and noninvasive procedures are discussed, along with current treatment options and how they relate to rising therapies. Specific highlights of this report include extensive research, company backgrounds, challenges, and validation techniques for therapeutic applications offered by the participating companies. These techniques include:
Implantable telescope technology
Mucosal penetrating products
Also available are complementary interviews with company representatives at the end of each section. The interviewees include:
President and CEO of Oraya Therapeutics
Marketing Director of VisionCare Ophthalmic Technologies
Chairman and CEO of Omeros
CMO of Kala Pharmaceuticals
Also included in this report is a demographic survey of researchers working in ocular disorders. Some of the concepts include ocular areas of research, promising therapeutic options, targets of interest, and challenges encountered.
To view the table of contents and know more details please visit Ocular Disorders: Rising Therapeutics, Technologies, and Devices report.